Related Experiment Video
Updated: Oct 30, 2025

Author Spotlight: Visualizing Single-Stranded DNA During DNA Repair for Therapeutic Insights
Published on: December 22, 2023
Iso-suillin-induced DNA damage leading to cell cycle arrest and apoptosis arised from p53 phosphorylation in
Yongxin Yan1, Shengjie Yao1, Zhiqiang Jia1
1The Basic Medical College, Hebei Medical University, Shijiazhuang, 050017, PR China.
Abstract:
Extensive investigations have revealed that iso-suillin, a secondary metabolite isolated from Suillus flavus, could induce cell cycle arrest and apoptosis in human chronic myeloid leukemia K562 cells, human hepatocellular carcinoma SMMC-7721 cell line, and human small cell lung cancer H446 cell line in vitro. In the present study, human lung cancer A549 cells were used to reveal the mechanism of iso-suillin's effects on lung adenocarcinoma, which were detected both in vitro and in vivo. Results showed that iso-suillin potently inhibited A549 cell proliferation through an early G1 arrest. Iso-suillin also induced A549 cell apoptosis in vitro. Phosphorylation of p53 at serines 15 and 20 may be one of the pivotal factors for cell cycle arrest and apoptosis after treatment of iso-suillin in A549 cells. Moreover, in an A549 xenograft model, tumor growth and progression could be inhibited by iso-suillin. Body weight change and some vital organs toxicity was also roughly examined, no significant toxic effects of iso-suillin were shown (at a dose of 5 mg/kg for each administration). The in vitro and in vivo anti-tumor effects implied that iso-suillin may act as a tumor growth inhibitor, and its induction of p53 phosphorylation is pivotal for cell cycle arrest and apoptosis in A549 cells.
Insights
Iso-suillin, a natural compound, inhibits lung cancer cell growth by causing cell cycle arrest and apoptosis. This compound shows potential as a tumor growth inhibitor with no significant toxicity in preclinical studies.
Area of Science:
- Natural Product Chemistry
- Cancer Biology
- Pharmacology
Background:
- Iso-suillin, a secondary metabolite from Suillus flavus, has demonstrated anti-cancer properties.
- Previous studies indicated iso-suillin induces cell cycle arrest and apoptosis in various cancer cell lines.
Purpose of the Study:
- To investigate the anti-cancer mechanism of iso-suillin on human lung adenocarcinoma A549 cells.
- To evaluate the in vitro and in vivo anti-tumor effects of iso-suillin.
Main Methods:
- In vitro studies using A549 cells to assess proliferation, cell cycle, and apoptosis.
- In vivo studies using an A549 xenograft mouse model to evaluate tumor growth inhibition.
- Assessment of p53 phosphorylation at serines 15 and 20.
- Evaluation of toxicity and body weight changes in vivo.
Main Results:
- Iso-suillin significantly inhibited A549 cell proliferation by inducing early G1 phase arrest.
- Iso-suillin promoted apoptosis in A549 cells in vitro.
- Tumor growth and progression were suppressed in the A549 xenograft model.
- p53 phosphorylation at serines 15 and 20 was identified as a key factor in iso-suillin's effects.
- No significant toxicity was observed at a dose of 5 mg/kg.
Conclusions:
- Iso-suillin exhibits potent in vitro and in vivo anti-tumor activity against lung adenocarcinoma.
- The anti-cancer effects of iso-suillin are mediated through the induction of p53 phosphorylation, leading to cell cycle arrest and apoptosis.
- Iso-suillin demonstrates potential as a therapeutic agent for lung cancer with a favorable safety profile.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation

